Send to

Choose Destination
See comment in PubMed Commons below
Eur J Heart Fail. 2010 Apr;12(4):319-22. doi: 10.1093/eurjhf/hfq017.

Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse.

Author information

  • 1Division of Cardiology/VCU Pauley Heart Center, Virginia Commonwealth University, 1200 East Broad Street, Richmond, VA 23298-0281, USA.
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk